Clinical Research Directory
Browse clinical research sites, groups, and studies.
CongenItal Naevus Cohort for Longitudinal Evaluation
Sponsor: Nantes University Hospital
Summary
Congenital Nevus (CN) is a pigmented skin lesion present at birth, which grows in size as the child grows. It can vary in appearance and is classified by its size, from small (less than 1.5 cm) to giant (greater than 40 cm). CN is associated with genetic mutations, mainly in the NRAS/BRAF genes. A large CN can lead to several clinical issues, including: Risk of neurological disorders: Large CN can be associated with neurological abnormalities such as neuro-meningeal melanosis, hydrocephalus, or brain malformations. These conditions may cause early neuro-developmental delays. The risk is not well understood and requires further studies. Risk of melanoma: The risk of developing melanoma is higher for a large CN but remains low for smaller ones. Increased monitoring is necessary during the early years for large and giant CN. Psycho-social impact: Parents often experience significant anxiety at birth due to the cancer risk and social stigma. As the child grows, a visible CN may impact their quality of life, particularly socially at school. Management of CN remains controversial, especially for those of medium to giant size or with multiple satellites. There is an urgent need for further research to clarify best practices in monitoring and treatment, including the need for routine brain imaging and criteria for surgical intervention. Ultimately, this study aims to deepen our understanding of CN, its associated neurological and melanoma risks, and the psycho-social challenges it poses, while striving to establish clear, evidence-based guidelines for monitoring and treatment to enhance patient outcomes and quality of life.
Official title: CIRCLE : CongenItal Naevus Cohort for Longitudinal Evaluation
Key Details
Gender
All
Age Range
0 Years - 24 Months
Study Type
INTERVENTIONAL
Enrollment
819
Start Date
2025-07-23
Completion Date
2031-07-23
Last Updated
2026-03-09
Healthy Volunteers
No
Interventions
Neurodevelopmental assessment
This assessment will be conducted using the ASQ-3 test. (ASQ-3 stands for Ages and Stages Questionnaires, Third Edition, which is a common screening tool for evaluating developmental progress in young children.)
Meeting with the parents
This meeting will evaluate the parents' acceptance of the lesion and their quality of life using the MARKS test (Measure of Acceptance of Skin Marks). The results will provide insights into how the parents perceive the lesion and how it impacts their daily lives.
Patient quality of life assessment
Collection of patient quality of life data
Locations (16)
Grasse Hospital
Nice, Alpes-Maritimes, France
Nice University Hospital and Lenval Hospital
Nice, Alpes-Maritimes, France
Marseille University Hospital
Marseille, Bouches-du-Rhône, France
Dijon University Hospital
Dijon, Côte-d'Or, France
La Réunion University Hospital
La Réunion, Département Et Région d'Outre-mer, France
Brest University Hospital
Brest, Finistère, France
Bordeaux University Hospital
Bordeaux, Gironde, France
Toulouse University Hospital
Toulouse, Haute-Garonne, France
Rennes University Hospital
Rennes, Ille-et-Vilaine, France
Tours University Hospital
Tours, Indre-et-Loire, France
Nantes University Hospital
Nantes, Loire Atlantique, France
Angers University Hospital
Angers, Maine et Loire, France
Nancy University Hospital
Nancy, Meurthe-et-Moselle, France
Saint Vincent de Paul Hospital
Lille, Nord, France
Paris Necker Hospital
Paris, Paris, France
CHU Lille
Lille, France